Hologic Showcases Developments in Next-Generation AI Solutions

By MedImaging International staff writers
Posted on 29 Nov 2023

Image: Genius AI Detection uses deep learning technology to find cancers with improved accuracy (Photo courtesy of Hologic)

Hologic, Inc. (Marlborough, MA, USA) is showcasing several recent developments in next-generation AI solutions at the 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 26 to 30. On the show floor and during multiple workshops, the global leader in breast imaging is unveiling advances that leverage AI to improve cancer detection, workflow, and patient satisfaction.

New to Hologic’s portfolio of Breast and Skeletal Health Solutions is its Genius AI Detection 2.0 solution, a next-generation deep-learning technology designed to improve breast cancer detection while reducing the number of false-positive markings per case. With more than a 70% reduction in false-positive markings per case when compared to Hologic’s ImageChecker CAD solution, Genius AI Detection 2.0 technology gives radiologists confidence that marked lesions are truly suspicious and warrant further review. Additionally, the new SecurView 12.0 solution enables more multimodality capabilities, including reading breast ultrasound cases directly in the SecurView viewer. When paired with Genius AI Detection 2.0, the new automated lesion correlation feature is enabled to allow for faster review of specific lesions.

Genius AI Detection 2.0 technology represents Hologic’s continued commitment to advancing and refining its AI roadmap. Customer feedback, research findings, and continuous improvements will inform future iterations of Genius AI Detection technology, as well as new AI products. Hologic is currently exploring new product features to drive toward even greater accuracy and efficient breast care, including real-time image quality and positioning feedback, short-term risk evaluations, automated reporting tools, and smart triage features. Visitors to Booth 1919 can experience Hologic’s comprehensive portfolio, including the Dimensions mammography portfolio, Affirm Contrast Biopsy software, I-View Contrast Enhanced Mammography software, and a full suite of breast biopsy and surgery solutions. Additionally, the company will host a CME-accredited symposium and lunch-and-learn sessions.

“We are building on our history of innovation in breast health with an exciting new AI-based solution that is designed to support the radiologist with improved cancer detection and a more efficient workflow — two factors that we know are critical for our customers,” said Erik Anderson, Division President, Breast and Skeletal Health Solutions, Hologic. “At this year’s RSNA meeting, we’re looking forward to engaging with industry leaders and affirming our commitment to advancing breast health through cutting-edge technology.”

Related Links:
Hologic, Inc.